Skip to content
DraconiticResearch
Search Sources API
209,932 studies31 sourcesUpdated 48 min ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,300 studies

  1. CYB5R1 drives stemness and malignant progression via STAM2/STAT3 in chemotherapy-enriched triple-negative breast cancer
    Zhongyu Wang, Jia Li, Lin Geng +11
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. H3K18 lactylation promotes Treg/Th17 imbalance via PTPRM-STAT3 axis in hepatocellular carcinoma
    Jianwei Yi, Zhonghuo Chen, Hengchang Zhu +9
    iSciencePeer-reviewedCC BY-NC 4.0Full textOncologyCell PressCrossrefEurope PMC
  3. Cross-species analysis reveals clonotypic T-cell remodeling underlying adrenal resistance to PD-1 blockade
    Natalie Liu, Jay Uppuluri, Clemens Van Dongen +24
    Research SquarePreprintCC BY 4.0Full textOncologyPMC
  4. Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.
    Miguel Suárez, Raquel Gómez-Molina, Ana M Torres +1
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  5. Chinese expert consensus on robot-assisted laparoscopic partial nephrectomy.
    Expert Group of the Research Project on Clinical Application Solutions of Domestic Laparoscopic Surgical Robot Systems
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  6. When actionable genomic findings do not translate into treatment in precision oncology
    Ewan K Cobran
    JNCI Cancer SpectrumPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. Nationwide real-world data on tumor-agnostic genomic companion diagnostics and comprehensive genomic profiling tests
    Yasushi Yatabe, Katsutoshi Oda, Hiroya Taniguchi +4
    Molecular and clinical oncologyPeer-reviewedCC BYFull textOncologyEurope PMCPMCEurope PMC
  8. Whole-genome sequencing-based tumor-informed circulating tumor DNA monitoring for early detection of recurrence in patients with solid tumors
    Mridula George, Gary S Schwartz, Wassim McHayleh +35
    The OncologistPeer-reviewedCC BY 4.0Full textOncologyPMC
  9. WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer
    Wafik S. El-Deiry, Alberto Hernando-Calvo, Shai Magidi +11
    OncotargetPeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Association of CDKN2A overexpression with poor prognosis, radioresistance, and immunosuppression in colorectal cancer
    Yaobin Lin, Zhihong Wang, Gaoda Ju +5
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  11. Profiling the MMP family genes as prognostic biomarkers in oral squamous cell carcinoma: from computational discovery to clinical validation in a South Indian cohort
    P. Sakthi Subhashini, T. Bharanidharan, D. Suresh Kumar +1
    Frontiers in bioinformaticsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  12. Breast cancer adaptation to oxygen stress: mechanisms of tumor survival, progression, and therapeutic resistance
    Emmanuel Ifeanyi Obeagu, Izuchukwu Hilary Edeoga
    Oncology reviewsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  13. Dietary exogenous microRNAs in the gut: biological effects, mechanistic evidence, and controversies
    Andrea Méndez-García, Marely Abigail García-Mendoza, Paulina Pérez-Martínez +5
    Frontiers in nutritionPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  14. Rectal colonization with multidrug-resistant organisms in adult acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective, longitudinal, single-center study
    Edoardo Tamellini, Chiara Bonetto, Annarita Mazzariol +8
    Frontiers in cellular and infection microbiologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  15. Addressing unmet clinical needs in treatment-resistant breast cancer: expanding the diagnostic–prognostic landscape through next-generation inflammatory signatures
    Emmanuel Ifeanyi Obeagu
    Oncology reviewsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  16. A nutrition–inflammation index weighted toward disease burden: the lactate dehydrogenase-to-albumin ratio in TP53-mutated myeloid neoplasms
    Xiaoqin Xin, Zongqi Wang
    Frontiers in nutritionPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  17. Orchestrating cancer stem cell plasticity: deubiquitinases as key regulators of EMT and metabolic rewiring
    Tao Qin, Yupeng Wang, Minhao Li +4
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  18. WRN deficiency generates oncogenic rearrangements at TA-rich tandem repeats
    Meng Wang, Hui Pan, Anastasia Samarkina +17
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  19. Pyruvate partitioning defines an immunosuppressive metabolic niche in colorectal cancer
    J. Zheng, B. Lian, S. Huang +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  20. Fibronectin silencing remodels the fibrotic bone marrow niche
    F. R. Calledda, V. Abbonante, M. F. Testa +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  21. Improved anti-tumor vaccination activity of necroptotic cells lacking ATG16L1-dependent unconventional autophagy
    J. Bandera-Linero, D. Ona-Sanchez, K. Stamatakis +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. HPV-Associated Tonsillar Intraepithelial Neoplasia and Oral High-Risk HPV mRNA as a Candidate Biomarker
    M. Mori, H. Tanaka, M. Suzuki +30
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  23. Preclinical Evaluation of Itareparib, a brain penetrant PARP1-selective radioligand, in Glioma Rat Model and Nonhuman Primate
    Peng Wen Tan, Nira Hernandez-Martin, Claudia Esposito-Zapero +14
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  24. Spatial epigenomics reveals ancestry-associated regulatory states linked to aggressive prostate cancer biology
    B. German Falcon, K.-L. Ho, J. Garbarino +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. Domain-resolved epitope mapping of B7-H3-targeting VHH-Fcs defines isoform-selective binders for antibody-drug conjugate development
    X. Fang, B. Chalopin, S. S. Gokturk +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv